Full Breakdown
Exodus of Scientists from the National Institutes of Health Under Trump Administration
3/6/2026, 8:24:51 PM
Decline of NIH Workforce
The National Institutes of Health (NIH), the largest public funder of biomedical research globally, has experienced a significant decline in its workforce during the Trump administration. Federal data indicates that the NIH's employee count dropped from approximately 21,100 in fiscal year 2024 to around 17,100, marking its lowest level in two decades. This reduction represents a loss of about 4,400 employees, or over 20% of its workforce. Most departures were voluntary, with roughly 80% of those leaving opting for retirement, resignation, or transfers, rather than being terminated.
Reasons for Departure
Scientists have cited a "hostile work environment" and bureaucratic hurdles as primary reasons for their early exits. Marc Ernstoff, a physician specializing in immunotherapy, stated that he left his position due to the challenges posed by the Trump administration, including restrictions on remote work. Alexa Romberg, an addiction prevention scientist, lamented the loss of federal grants that hindered her research on tobacco prevention, a significant contributor to early morbidity and mortality. Many researchers reported that their work was stalled due to delays in accessing necessary equipment and supplies, as well as restrictions on communication outside the agency.
Impact on Research and Public Health
The exodus of scientists has raised concerns about the NIH's ability to address pressing public health issues. Daniel Dulebohn, a former researcher at Rocky Mountain Laboratories, described the situation as a "fundamental destruction" of the agency's capabilities. Laura Stark, a Vanderbilt University associate professor, warned that the loss of NIH staff could shift research focus toward private industry, driven by profit motives rather than public health interests. Jennifer Troyer, who left the National Human Genome Research Institute, highlighted that her division lost about two-thirds of its staff, severely impacting its ability to oversee critical research and grant allocations.
Official Responses
Emily Hilliard, a spokesperson for the Department of Health and Human Services (HHS), asserted that the agency is focusing on evidence-based research and is still recruiting top talent. Hilliard emphasized that a "major reset" was necessary to streamline operations and return to pre-pandemic employment levels. However, many scientists remain skeptical about the NIH's future effectiveness in fulfilling its public health mission.
Future Implications
The ongoing decline in NIH staffing could jeopardize the United States' status as a leader in biomedical research. Experts warn that halted research may not be resumed elsewhere, potentially delaying advancements in treatments and public health initiatives. Stanley Perlman, a virologist at the University of Iowa, noted that the loss of access to ongoing research could hinder the ability to reproduce and adapt findings for American health needs.
Verbatim Quotes
- “I was not ready at all to retire,” — Marc Ernstoff, Physician
- “There’s been a fundamental destruction,” — Daniel Dulebohn, Former NIH Researcher
- “We just don’t have people who are now able to pursue research for the public good,” — Laura Stark, Associate Professor, Vanderbilt University
- “At what point do you finally say, ‘Enough is enough’ and ‘We’re not being effective anymore’?” — Philip Stewart, Former NIH Scientist
The NIH's workforce challenges reflect broader implications for public health and biomedical research in the United States, raising concerns about the future of scientific inquiry and disease treatment capabilities.
